Literature DB >> 9338464

T-cell lymphocytosis associated with lymphocyte-rich thymoma.

A D Barton1.   

Abstract

BACKGROUND: Peripheral T-cell lymphocytosis is found on very rare occasions in patients with thymomas. The immunophenotypic features and clonality of the lymphocytes in tumor and peripheral blood now are elucidating this enigmatic phenomenon.
METHODS: The author presents what is believed to be the seventh case of peripheral T-cell lymphocytosis associated with thymoma and reviews the previous six cases. The pathology slides of the thymoma were reviewed with a pathologist who confirmed the presence of neoplastic thymic epithelium with cytokeratin stains. Immunophenotyping by flow cytometry was performed at Dianon Systems, Inc., on both the thymoma cells and cells in the peripheral blood. In addition, gene rearrangement analysis was performed on the peripheral lymphocytes using the previously described Southern blot analysis technique with immunoglobulin probes (heavy chain, kappa light chain, and lambda light chain) and T-cell receptor gene probes (beta and gamma chains).
RESULTS: Analyses of the T cells within the thymoma and the peripheral blood confirm that the peripheral T cells are both polyclonal and more mature than those populating the thymoma. Clearly the peripheral T cells are not themselves neoplastic, and yet they represent more than physical "spillover" of the immature tumor-related T cells.
CONCLUSIONS: Peripheral T-cell lymphocytosis occurs rarely with locally aggressive, lymphocytic thymomas. Although it is clear that these cells are not neoplastic, as they are in other T-cell proliferative disorders, the etiology of this unusual phenomenon remains obscure and may reflect the perturbation of systemic immunoregulation that accompanies thymic neoplasia. It is important to differentiate this condition from T-cell lymphomas or leukemia to treat affected patients appropriately.

Entities:  

Mesh:

Year:  1997        PMID: 9338464     DOI: 10.1002/(sici)1097-0142(19971015)80:8<1409::aid-cncr7>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Survival after subsequent non-Hodgkin's lymphoma and non-small cell lung cancer in patients with malignant thymoma.

Authors:  Jacob S Parzen; James E Bates; Michael T Milano; Sughosh Dhakal
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

Review 2.  Thymoma and multiple malignancies: a case of five synchronous neoplasms and literature review.

Authors:  James S Welsh; Sarah A Thurman; Steven P Howard
Journal:  Clin Med Res       Date:  2003-07

3.  Unusual association of CD8+ T-cell lymphocytosis with invasive thymoma.

Authors:  Hee Jin Huh; Jae-Woo Chung; Hyun Jung Lee; Seok Lae Chae
Journal:  Blood Res       Date:  2015-09-22

4.  CD4 and CD8 double-negative immunophenotype of thymoma-associated lymphocytes in a dog.

Authors:  Yvonne M Wikander; Kaori Knights; Calli Coffee; William Vernau; David S Biller; Mary Lynn Higginbotham; Nora L Springer
Journal:  J Vet Diagn Invest       Date:  2020-08-19       Impact factor: 1.279

5.  Marked cytoreduction of a lymphocyte-rich mediastinal thymoma with neoadjuvant chemotherapy in a cat.

Authors:  Linda J Tong; Giselle Hosgood; Julien Labruyère; Susan L Bennett; Louise FitzGerald; Robert E Shiel
Journal:  JFMS Open Rep       Date:  2015-06-01

Review 6.  Bone metastasis of malignant thymomas associated with peripheral T-cell lymphocytosis.

Authors:  Luo Zhao; Xi Zhou; Zheng Li; Yong Liu
Journal:  BMC Surg       Date:  2016-08-19       Impact factor: 2.102

7.  Assessment of the prognostic role of neutrophil-to-lymphocyte ratio following complete resection of thymoma.

Authors:  Piergiorgio Muriana; Angelo Carretta; Paola Ciriaco; Alessandro Bandiera; Giampiero Negri
Journal:  J Cardiothorac Surg       Date:  2018-11-19       Impact factor: 1.637

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.